Drug intelligence / Profile preview

pinellia pedatisecta extract

Development stage
Preclinical
Lead developer
Shanghai Institute of Materia Medica
Administration
Oral, Intraperitoneal
01

Overview

Pinellia pedatisecta extract (PE) is a novel lipid-soluble botanical extract derived from the rhizome of *Pinellia pedatisecta* Schott, a traditional Chinese medicinal plant historically used for its anti-inflammatory and anti-tumor properties. Developed through a collaboration between the Shanghai Institute of Materia Medica (Chinese Academy of Sciences) and the Obstetrics and Gynecology Hospital of Fudan University, PE is being investigated as a research-stage antineoplastic agent, particularly for the treatment of cervical cancer. Its mechanism of action is multifaceted, involving the induction of apoptosis and necrosis in cancer cells, activation of the DNA damage response (DDR) pathway, and modulation of the tumor immune microenvironment. Specifically, PE has been shown to suppress tumor-associated dendritic cells (TADCs) by inhibiting SOCS1 signaling, thereby enhancing CD4+ and CD8+ T cell immune responses. Additionally, it exhibits synergistic cytotoxicity when combined with cisplatin by inhibiting the HPV E6/p53 signaling pathway, restoring p53 function, and upregulating pro-apoptotic proteins such as BAX and caspases.

Other names
Pinellia pedatisecta Schott extractPPS extractrhizome of Pinellia pedatisecta extract
02

Targets

SOCS1 (Suppressor of cytokine signaling 1)CASP3 (Caspase-3)BAX (Apoptosis regulator BAX)CASP9 (Caspase-9)E6/E7 (HPV E6/E7 oncoproteins)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on pinellia pedatisecta extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pinellia pedatisecta extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call